Cryptocurrencies have entered the investment portfolios of 16% of Brazilian investors, and 56% of surveyed non-investors express interest in entering the market.
Foresight News reported, according to Livecoins, that cryptocurrency has entered the portfolios of 16% of Brazilian investors, and 56% of respondents who have never invested in crypto assets expressed interest in entering the market in the future. 61% of Brazilians see a Bitcoin decline as a buying opportunity, and among investors already holding crypto assets, this proportion rises to 79%. However, 62% of respondents said it is difficult to understand crypto terminology, 76% believe the market is too complex, and 55% of respondents consider whether a platform is regulated as the most important factor when choosing a crypto investment platform.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
A key leap toward the internationalization of the Korean won: The Bank of Korea launches a trial run of its 24/7 international settlement system, with full deployment set for January next year.
The Bank of Korea officially launched the trial operation of the "BOK Won International Payment Network" on Monday local time.
Offshore oil and gas module equipment company VME (VME.US) aiming for Nasdaq listing, plans to raise up to 30 million USD
Offshore oil and gas process module and separation equipment company VME Companies has applied for an IPO on Nasdaq, aiming to raise up to $30 million, with Kingswood as the sole bookrunner.
Hypertension drug developer Retension (RTSN.US) applies for US listing, plans to raise $58 million.
U.S. hypertension drug developer Retension Pharmaceuticals filed documents with the SEC last Friday, planning to raise up to $58 million through an initial public offering (IPO).
Pfizer (PFE.US) overseas price increase gains to be shared with the U.S. government: "Most Favored Nation" contract revealed, over twenty transactions still confidential
According to reports, under a new contract with the U.S. Department of Health and Human Services, Pfizer will share higher overseas drug revenues with the United States.
Crypto prices
More
